Timothy I. Maudlin, Director at Sucampo Pharmaceuticals, Inc. (SCMP), bought 32,870 shares at $9.82 ($323K) on 2013-05-15, disclosed to the SEC on 2013-06-05.
Open-market purchase of $323k SCMP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PS | SELL | 2020-06-16 | $910K | — | Filing → |
| AYX | SELL | 2020-06-11 | $2.2M | — | Filing → |
| AYX | SELL | 2020-02-25 | $3.2M | — | Filing → |